Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main Cure Vac N.V. Transaction History
Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main
- $92 Billion
- Q2 2025
A detailed history of Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main transactions in Cure Vac N.V. stock. As of the latest transaction made, Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main holds 15,512 shares of CVAC stock, worth $84,850. This represents 0.0% of its overall portfolio holdings.
Number of Shares
15,512
Previous 173,084
91.04%
Holding current value
$84,850
Previous $479,000
82.46%
% of portfolio
0.0%
Previous 0.0%
Shares
17 transactions
Others Institutions Holding CVAC
# of Institutions
103Shares Held
14.2MCall Options Held
270KPut Options Held
114K-
Black Rock Inc. New York, NY2.25MShares$12.3 Million0.0% of portfolio
-
Alpine Associates Management Inc. Englewood Cliffs, NJ1.97MShares$10.8 Million0.58% of portfolio
-
Bill & Melinda Gates Foundation Seattle, WA1.57MShares$8.58 Million10.6% of portfolio
-
Qube Research & Technologies LTD London, X01.18MShares$6.47 Million0.01% of portfolio
-
Water Island Capital LLC New York, NY957KShares$5.23 Million1.03% of portfolio
About CureVac N.V.
- Ticker CVAC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 187,467,008
- Market Cap $1.03B
- Description
- CureVac N.V., a clinical-stage biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA). It is developing prophylactic vaccines, such as mRNA-based vaccine candidates CV2CoV, which is in Phase 1 clinical trial against SARS-CoV-2; CV7202, a prophylactic mRNA-based vaccine, which ...